Antibody-mediated depletion of CD8+ T cells during treatment with polyI:C combined with the L1165-173 minimal peptide epitope abrogated protection (Fig. 2D), indicating a critical contribution of CD8+ T cells to the protective anti-tumor response (Fig. 2C, D). The gene discussed is CD8A; the disease is neoplasm.